The ESMO Congress is the yearly appointment in Europe for nearly 30,000 clinicians, researchers, oncology nurses, patient advocates, journalists and representatives of the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology and translate science into better cancer patient care.
The ESMO 2021 virtual programme will be developed by a committee composed of more than 300 international experts and will span from basic research to the latest discoveries in immunotherapy of cancer, from oncology nursing to palliative care, from rare cancers to approval of medicines.
The 8th Immunotherapy of Cancer Conference (ITOC8) to be held virtually from October 8 - 9, 2021 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Day One: Discovery & Development: Cell Therapies & Combination Therapies / Biomarkers in Immuno-Oncology / Mechanisms & Novel Treatments in Autoimmunity
Day Two: Discovery & Development: Intratumoural Immunotherapies & Antibody Therapies / Translational & Preclinical Development / Immunotherapy: A Clinician’s Perspective.
The Leipzig Immune ONcology (LION) Virtual Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.
Virtually or in person, you choose.
The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. and virtually. Schedule at a glance here" https://www.sitcancer.org/2021...
Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.
- Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, oncolytic viruses, bispecific drugs and cancer vaccines.
- Advance your understanding of topical technological innovation, from single cell analysis tools and NGS approaches to biomarker technologies like mass spectrometry, immunohistochemistry and flow cytometry.
- Examine the latest challenges and technological innovations in preclinical and clinical development with discussions on animal modelling techniques and screening strategies in preclinical development along with the challenges of clinical trial design.
The sessions of this new edition of the International Congress of Micro-immunotherapy will cover both clinical and research topics from the fields of immunology and metabolism.
The focus of the IRCI symposium allows prominent scientists and clinicians to present their recent data in the multidisciplinary area of immunology in cancer and/or infectious diseases. As in our prior 1st IRCI symposium in 2017, our goal is to keep the number of participants limited thereby driving increased discussion between leaders in the field and attendees, thus strengthening as well as defining immunological research and curative therapies in the near future.
The IRCI meeting is organized by researchers from two leading centers in Lyon, the CIRI and CRCL. The first edition gathered more than 340 people from all around the world. This 2022 edition will highlight the recent discoveries in innate and adaptive immunity, immuno-metabolism; immunotherapy and (epi)genetics.